A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer

NCT04806945 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The sponsor terminated the trial.

Conditions

Cervical Cancer

Interventions

DRUG: HLX10
DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Placebo to HLX10

Sponsor

Shanghai Henlius Biotech